Brief: Armata Pharmaceuticals Announces Second Quarter 2022 Results And Provides Corporate Update
11/08/2022 22:20
Aug 11 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2022
RESULTS AND
PROVIDES CORPORATE UPDATE
* ARMATA PHARMACEUTICALS INC - GRANT REVENUE OF
APPROXIMATELY $1.9
MILLION FOR THREE MONTHS ENDED JUNE 30, 2022
* ARMATA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.26
Source text for Eikon: ID:nPn80BjqXa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles